The Venality of Value Denial
Much legitimate consternation over the recent 60 Minutes segment on the cost of oncology meds.
But why is anyone surprised? Sunday’s broadcast is only the most recent example of “value denial” – and it’s important to understand the program not as a unique and unfortunate incident, but as a set-up for ASCO’s pending announcement on it’s new methodology for determining the cost-effectiveness of new cancer medicines. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - October 7, 2014 Category: Pharmaceuticals Source Type: blogs
The Golden Rule of Healthcare
The economics of American healthcare are dictated by the Golden Rule: "He who has the gold makes the rules.” And those rules reward corporate greed at the expense of physician empowerment and patient care. The gold in this case is the money leveraged by pharmacy benefit managers (PBMs) to reimburse patients for their medicines. And it’s a golden hammer used to negotiate lower prices from pharmaceutical companies. But where do those savings go, and what is the impact on a physician's ability to practice medicine and — most importantly, therapeutic outcomes for patients? (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - September 10, 2014 Category: Pharmaceuticals Source Type: blogs
Cognito ergo IPR
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - September 5, 2014 Category: Pharmaceuticals Source Type: blogs
Scheduling Scheduling
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - August 27, 2014 Category: Pharmaceuticals Source Type: blogs
Facts, Damn Facts, and Opioids
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - August 25, 2014 Category: Pharmaceuticals Source Type: blogs
Fragile Fraternity
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - August 14, 2014 Category: Pharmaceuticals Source Type: blogs
Karen Ignagni: Bending the curve -- and the truth -- about the $1000 Pill
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - August 4, 2014 Category: Pharmaceuticals Source Type: blogs
Biosimilars: Like a Deer in the Headlines
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - August 4, 2014 Category: Pharmaceuticals Source Type: blogs
Multilingual Labels Lost in Translation
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 31, 2014 Category: Pharmaceuticals Source Type: blogs
The New Pharma ROI -- Return on Integrity
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 30, 2014 Category: Pharmaceuticals Source Type: blogs
Lies, Damn Lies, and the Dangerous Myths behind the Biosimilar Naming Issue
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 23, 2014 Category: Pharmaceuticals Source Type: blogs
Can E&C Lift the Off-Label Gag Order?
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 22, 2014 Category: Pharmaceuticals Source Type: blogs
Pet Peeves
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 15, 2014 Category: Pharmaceuticals Source Type: blogs
US Health System: Most Valuable and Best Performing
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - June 17, 2014 Category: Pharmaceuticals Source Type: blogs
Screw Value.. We Want The NICE Price..
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - June 17, 2014 Category: Pharmaceuticals Source Type: blogs
